Time-Driven Activity-Based Costing for Cataract Surgery in Canada: The Case of the Kensington Eye Institute.


Journal

Healthcare policy = Politiques de sante
ISSN: 1715-6580
Titre abrégé: Healthc Policy
Pays: Canada
ID NLM: 101280107

Informations de publication

Date de publication:
05 2021
Historique:
entrez: 15 6 2021
pubmed: 16 6 2021
medline: 1 12 2021
Statut: ppublish

Résumé

Time-driven activity-based costing (TDABC) has received considerable attention globally as a way to measure value in healthcare systems. This study aimed to apply TDABC for cataract surgery at the Kensington Eye Institute (KEI). During a field evaluation, a detailed process map was created for cataract surgery at KEI. The amount of resource use in terms of providers, equipment, space and consumables was calculated to determine the total costs of care. The average patient journey lasted 76 minutes, with 13 minutes of the surgical procedure occurring in the operating room (OR). The average procedure's cost per case was $545.28, which included consumables (34.40%), space and equipment (23.702%), personnel (11.69%), overhead (30.27%) and OR (57%). KEI cataract operation was at approximately 50% capacity due to funding limits. The TDABC process map and costing allow centres to have data-driven support tools for care redesign and optimization.

Identifiants

pubmed: 34129481
pii: hcpol.2021.26496
doi: 10.12927/hcpol.2021.26496
pmc: PMC8200830
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-108

Informations de copyright

Copyright © 2021 Longwoods Publishing.

Références

CMAJ. 1994 Mar 15;150(6):889-94
pubmed: 8131122
Harv Bus Rev. 1989 Jul-Aug;67(4):77-85
pubmed: 10293841
Int J Qual Health Care. 2011 Feb;23(1):83-93
pubmed: 21123187
Inquiry. 1995-1996 Winter;32(4):476-81
pubmed: 8567084
Healthc Q. 2018 Jan;20(4):48-53
pubmed: 29595428
J Clin Med Res. 2018 Apr;10(4):314-320
pubmed: 29511420
Health Policy. 2017 Jul;121(7):755-763
pubmed: 28535996
Int J Health Plann Manage. 2019 Oct;34(4):e1736-e1746
pubmed: 31429493
Ann Emerg Med. 2016 Jun;67(6):765-772
pubmed: 26365921
Nurs Econ. 1993 Nov-Dec;11(6):342-9
pubmed: 8114958
Health Care Manag (Frederick). 2013 Jan-Mar;32(1):23-36
pubmed: 23364414
Health Serv Res. 2019 Dec;54(6):1357-1365
pubmed: 31429482
BMC Health Serv Res. 2010 Jun 07;10:154
pubmed: 20529299
Int Forum Allergy Rhinol. 2013 Sep;3(9):748-54
pubmed: 23704081

Auteurs

Hamid Sadri (H)

Director, Policy Health Economics and Outcomes Research and Health Technology Assessment, Medtronic ULC, Brampton, ON.

Sara Sinigallia (S)

Product Manager, Medtronic ULC, Brampton, ON.

Mahek Shah (M)

Director and Senior Researcher, Harvard School of Public Health, Boston, MA.

Jason Vanderheyden (J)

National Director, National Director Value-Based Healthcare, Medtronic ULC, Brampton, ON.

Bernard Souche (B)

Director, Health System Strategy, Medtronic ULC, Brampton, ON.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH